The latest news from ItaCRIN and its partners

News

TRANSVAC2 offers a support to the development of vaccines against COVID19

Wednesday, April 8, 2020,

TRANSVAC supports innovation for both prophylactic and therapeutic vaccine development. High quality technical services across four different service platforms are offered: Technology (for process development and GMP production), Immunocorrelates & Systems Biology, Animal models, and support for Clinical Trials. Academic and non-academic research groups, including SMEs, can apply to benefit from the expertise, reagents, and facilities offered by TRANSVAC2 to accelerate the development of their vaccines.

TRANSVAC2 extended the deadline for submission of applications for the M13 and M14 training module on Systems Biology of Vaccinology and Regulatory aspects of vaccine development
For more information, please visit: https://www.transvac.org/

ECRIN contribution to COVID-19 research

Wednesday, April 1, 2020,

In the COVID-19 emergency, ECRIN has established, with its national partners, a COVID-19 taskforce with its national partners, working on a fast-track procedure for access to, and provision of services:

  1. Review and digest the scientific literature on COVID clinical trials
  2. Develop a metadata repository for COVID trials making all the non-sensitive COVID-19 trial data accessible
  3. Develop a database on the regulatory, ethical and data protection fast track approvals across all European countries
  4. Ensure preparedness of its national clinical trial unit (CTU) partners for COVID trials
  5. Combine and coordinate national initiatives to promote multinational rather than national trials, including through connection with national funders, sponsors investigators and CTUs
  6. Develop partnership with national and pan-European investigation networks on infectious diseases and intensive care
  7. Outreach to investigators, sponsors, patients, policymakers, funders, and citizens
  8. International cooperation and outreach, including with WHO and through CRIGH and other initiatives.

For any further information please contact ECRIN’s Head of Clinical Operations Unit, Sabine Kläger via mail at sabine.klager@ecrin.org

#StopTheSpread

Monday, March 30, 2020,

Consistent with Covid-19 outbreak and subsequent measures adopted by the Italian Council of Ministers in conjunction with the Ministry of Health, no-profit Sponsors, CTUs/CROs and many pharmaceutical companies have applied or extended smart-working in order to continue their activities related to clinical trials and to assure at the same time the highest possible protection of the personnel involved. To this regard, please see the AIFA announcement.

A NEW CTU JOINED ITACRIN NETWORK!

Friday, February 21, 2020,

It is our great pleasure to announce that CD PHARMA became part of ItaCRIN.
Our Network is growing fast,

Welcome CD PHARMA!

www.cdpharma.it

EJP RD – RDR Challenges NETWORKING EVENT ANNOUNCEMENT

Friday, January 10, 2020,

Summary information on the RDR Challenges Call

The RDR Challenges call will be launched in March 2020.

It foresees selection, evaluation and funding of projects in a 2-stage process. Challenges must be solvable in a short time period of 30 months with first milestones/deliverables at M18. A first Scientific Evaluation Committee (SEC) meeting will evaluate applications responding to the proposed challenges for the first 18-month phase grant. The aim of this selection process is to fund one project for each proposed challenge. Following the completion of the first phase (after 18 months), the applicants submit a report demonstrating the work undertaken during the study and, if appropriate, an application for phase 2 funding. The SEC will examine the results from the 1st phase and evaluate what has been delivered in the specific timeline and how the applicants met the milestones/deliverables. After positive evaluation, the SEC will validate projects for the second phase grant.

The total budget of 1.5 Mio€ funding from the European Commission allows for 4 projects to be funded (375 000 € per project).

The involved industry partners who identified a challenge will join the consortium of applicants once selection is made by the SEC and will co-fund (in cash and in kind) the granted project.

THE NETWORKING EVENT FOR THE RDR CHALLENGES CALL WILL BE HELD ON 3rd MARCH 2020 IN PARIS

For more informations, please click here: http://www.ejprarediseases.org/index.php/funding-schemes/rare-diseases-challenges/

Networking Support Scheme is open

Tuesday, March 3, 2020,

The EJP RD (European Joint Program Rare Diseases) project has opened (on a continuous basis-no deadline) a “call” to provide financial support for organizing workshops to share knowledge on rare diseases.

 Eligible applicants to apply for the NSS are health care professionalsresearchers and patient advocacy organizations from the following countries involved in the EJP RD (in alphabetical order): Armenia*, Austria, Belgium, Bulgaria*, Croatia*, Czech Republic*, Denmark, Estonia*, Finland, France, Germany, Georgia*, Greece, Hungary*, Ireland, Israel, Italy, Latvia*, Lithuania*, Luxembourg, Malta*, Norway, Poland*, Portugal, Romania*, Serbia*, Slovakia*, Slovenia*, Spain, Sweden, Switzerland, The Netherlands, Turkey*, United Kingdom.

The application template with the link to the electronic proposal submission system
ProjectNet light can be found at the EJP RD website: http://www.ejprarediseases.org/index.php/networking-support/ 

ANNOUNCEMENT JOINT TRANSNATIONAL CALL 2020

Monday, December 16, 2019,

“Multidisciplinary Research Projects on Personalised Medicine –

Pre-/Clinical research, Big Data and ICT, Implementation and User’s Perspective”


ERA PerMed is an ERA-NET Cofund, supported by 32 partners of 23 countries and cofunded by the European Commission (EC). The funding organisations participating in this call particularly wish to promote innovative interdisciplinary collaboration and to encourage translational research proposals. The available budget for this call is 27 Mio € (approx.).


Opening of online submission tool: 16 December 2019

Submission deadline for pre-proposals: 5 March 2020 (17:00 CET) 

Submission deadline for full-proposals: 15 June 2020 (17:00 CEST)

For more informations, click here: ERA PerMed website 

November 2019 Newsletter is now online!

Friday, November 29, 2019,

ECRIN's newsletter provides relevant updates on ECRIN's work. 

Click here for the new issue: November 2019 

To sign up, please click here.

1